Distributed by

CATALENT INDIANA LLC

Featured products of Catalent Indiana

Imfinzi

Imfinzi conc for soln for IV infusion 120 mg/2.4 mL

durvalumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF03 - durvalumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Imfinzi conc for soln for IV infusion 500 mg/10 mL

durvalumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF03 - durvalumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Distributed by AstraZeneca

Imfinzi

Imfinzi conc for soln for IV infusion 120 mg/2.4 mL

durvalumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF03 - durvalumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Imfinzi conc for soln for IV infusion 500 mg/10 mL

durvalumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF03 - durvalumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.